medtronic fy17 integrated performance report ceo letter 3 responsible supply management 26 company overview 4 supplier quality management 26 company 4 responsible supply management 26 organizational profile 4 supplier diversity 27 global footprint 5 ethic sale marketing 29 sustainability risk opportunity 6 ethical business conduct 29 sustainability material issue 6 customer data security 30 sustainability management 6 working responsibly company 31 reducing sustainability risk 7 governance engagement 32 creating opportunity 8 corporate governance 32 economic contribution society 9 ethical workplace 33 financial performance 9 public policy 34 return shareholder 10 stakeholder engagement 34 compensation wage 11 operation 35 tax 11 management approach 35 expenditure 11 operational footprint 36 acquisition investment 12 energy use ghg emission 36 financial assistance 12 managing waste 37 philanthropy 12 water 38 value society priority 15 employee 39 access 16 global workforce 39 therapy innovation 16 investing workforce 39 economic value 17 employee engagement 40 expanding global access 18 inclusion diversity 40 product quality 21 employee compensation 41 responsibility quality 21 safety wellness 41 maintaining quality facility 22 data summary 42 product use performance 22 report 44 clinical trial 23 scope data 44 preclinical research 24 assurance forwardlooking statement 44 product stewardship 25 information 44 approach 25 integration index 45 integrated reporting medtronic 45 nongaap financial measure 47 ceo letter 55 year pursued mission alleviate pain donating 1018 million charitable cause corporate restore health extend life value instrumental cash contribution giving medtronic foundation earning trust partner customer employee result product donation employee volunteering 70 million people benefited medtronic technology service investing 76 million employee training solution year ever development program achievement come time healthcare system face mounting achieving four five 2020 environmental performance economic pressure leaving million unable benefit modern goal including reduction energy emission waste water medical technology global healthcare leader medtronic integral part solution addressing industry biggest challenge looking ahead continue work toward key business sustainability objective help u transform way healthcare extending existing therapy emerging market delivered innovation partnership critical success increasing access people contributing revenue growth innovative product process help u bring effective treatment fy17 revenue emerging market grew doubledigit range1 people partnership healthcare provider total annual revenue increased approximately 5 percent1 globally governmental organization others help multiply effort continued focus achieving mission improve patient life around world sustainability critical business performance helping u mitigate mission remain guide meeting challenge future risk enhance quality increase efficiency drive innovation look forward sharing progress coming year annual integrated report outline performance across important sustainability issue global access care product quality product stewardship responsible supply management ethic sale marketing continue innovate meet healthcare need growing global population im proud many success achieved omar ishrak fy17 including chairman chief executive officer investing 22 billion research development representing 74 percent net sale launching medtronic lab new initiative designed deliver financially sustainable business expand access reduce health inequality emerging market investing 1397 million capacity building training medical professional 226 million patient education 1 figure represent comparison prior year constant currency constant week basis nongaap ceo letter 3 company overview medtronic improving healthcare people organizational profile place ever among world largest medtronic four operating segment cardiac vascular minimally medical technology service solution company invasive therapy restorative therapy diabetes group guided mission alleviate pain restore health separated business division deliver wide range medical extend life helping u transform million life every year technology therapy service solution fy17 realigned division within restorative therapy group include spine brain company therapy pain therapy specialty therapy deliver innovative service solution hospital physician clinician patient approximately 160 country goal medtronic operating segment trusted partner transformation healthcare meaningful fy17 total sale business division innovation expanding global access therapy three total net sale 297 billion strategic priority operating segment fy17 net sale therapy innovation see access business division billion globalization see expanding global access cardiac vascular group 105 economic value see economic contribution society cardiac rhythm heart failure coronary structural heart aortic peripheral vascular medtronic fy17 snapshot minimally invasive therapy group 99 surgical solution number employee 91000 patient monitoring recovery number country operate approximately 160 restorative therapy group 74 spine number location 260 brain therapy specialty therapy research development spend 22 billion pain therapy number patent 53000 diabetes group 19 intensive insulin management patient served 70 million nonintensive diabetes therapy diabetes service solution company overview 4 global footprint fy17 net sale external customer region million total net sale 29710 greater china 1589 5 annual research development spend million asia paciÔ¨Åc 3443 12 fy15 1640 fy16 2224 europe fy17 2193 middle east africa 6739 23 america fy15 based medtronic fiscal year reported reflects partial year contribution covidien 17939 60 transaction closed jan 16 2015 company overview 5 sustainability risk opportunity fulfilling mission transforming people life additional material issue identified review include corporate making greatest contribution society bring governance device security financial strength philanthropy postmarket social environmental benefit promoting high sustainability surveillance stakeholder engagement talent trial data standard across operation product supply chain explain approach priority sustainability issue business responsibly sustainably help u mitigate integrated report gri supplement risk reduce operating cost enhance reputation employer trusted partner sustainability management ssc develops strategy oversees sustainability performance sustainability material issue risk engagement disclosure recognition committee meet focus sustainability issue important least twice year includes leader business function across business stakeholder identified material issue fy14 company chief financial officer sscs executive champion consulting internal external stakeholder including healthcare take implementation social environmental responsibility provider policymakers investor fy17 sustainability seriously manage issue daily operation steering committee ssc reviewed strategy priority following function sustainability priority environmental health safety sustainability ehss access care working health system around world sharing ethic compliance technology service resource expertise remove barrier affordable treatment chronic disease global communication product quality ensuring product service clearly comply global quality highest standard safety reliability global strategy product stewardship minimizing lifecycle footprint product packaging design innovation human resource responsible supply management collaborating supply chain investor relation develop longterm relationship enhance product quality legal worker right environmental protection regulatory ethic sale marketing leading industry trusted partner commitment ensure responsible business practice philanthropy marketing communication promotion product service procurement sustainability risk opportunity 6 reducing sustainability risk manage sustainability risk part overall risk management strategy see fit within significant business risk see risk factor included form 10k 10q filing u security exchange commission cannot guarantee even exhaustive effort fully mitigate prevent impact business success table outline top sustainability risk area manage sustainability risk area manage risk evolving ethical social government affair human resource ehss procurement group monitor relevant regulation environmental regulation global market legal compliance team oversee compliance regulation engage industry organization regulator educate industry perspective prepare potential pending regulation failure meet customer design program meet exceed customer requirement aspect sustainability including sustainability requirement quality access environment labor practice responsible supply management enhanced requirement global conduct related human right labor standard fy16 established responsible supply management function fy17 developed foundational element program including release global human right labor standard policy increasing cost endof incorporate criterion development process consider product environmental impact productlife obligation throughout lifecycle commitment product stewardship includes effort reclaim recycle product end useful life sustainable technology business also aim reduce cost endoflife obligation minimizing use hazardous material reputational damage office ethic compliance train employee comply code conduct clear unethical behavior process report act concern also offer additional compliance training employee certain role mitigate risk corruption misconduct sustainability risk opportunity 7 ensuring business continuity meeting customer expectation business continuity management program proactively identifies healthcare partner want work business share manages risk could result disruption operation supply value must demonstrate strong credential ethical environmental chain key focus area social issue meet customer requirement win new business remain partner choice business continuity planning developing strategy designed ensure continue operate meet demand adverse circumstance driving business efficiency setting goal energy use emission waste generation water use crisis management mobilization coordinating response help u minimize environmental impact operational cost case crisis 2020 sustainability goal using fy13 baseline reduce emergency response establishing procedure keep people asset safe minimize environmental impact emergency energy use per unit revenue 15 percent response recovery planning response deal greenhouse gas ghg emission per unit revenue 15 percent failure technology reinstate affected infrastructure nonregulated waste per unit revenue 15 percent support business continuity regulated waste per unit revenue 10 percent crisis management team follow robust protocol manage issue effectively coordinate response across company issue water use per unit revenue 10 percent arise could significant impact business team notify medtronic global command center corporate crisis filter information progress toward sustainability goal see operation team determines appropriate response corporate crisis team update executive committee regularly progress responding investor investor recognize strong performance sustainability indicator creating opportunity forwardlooking management proactive risk mitigation medtronic included dow jones sustainability index since 2008 sustainability program managing risk also help ftse4good index since 2001 submit environmental data cdp u generate new business opportunity strengthen relationship annually also report indicator set global reporting initiative customer improve efficiency meet investor customer gri sustainability accounting standard board gri supplement regulatory requirement leading valuebased healthcare traditional healthcare system based payment product service rather result lead rising healthcare cost suboptimal patient outcome advocate valuebased healthcare vbhc system payment based ability product service improve patient outcome relative cost current vbhc offering fall three category therapy optimization episodic bundle chronic care management information vbhc strategy approach see economic value sustainability risk opportunity 8 economic contribution society contribution society linked success company grow business nongaap generally reach patient contribute local economy deliver consistent return accepted accounting shareholder make important economic contribution job create tax principle financial measure referenced throughout pay capital investment make corporate donation grant channeled report identified medtronic foundation charitable giving provide support improve access nongaap measure healthcare underserved community reconciliation nongaap measure financial performance directly comparable strong financial performance ensures deliver consistent growth return also contributing measure determined using local economy live work fy17 made meaningful progress core growth strategy u gaap please see therapy innovation globalization economic value result delivered record revenue 297 billion section titled nongaap increase 3 percent reported basis approximatively 5 percent constant currency constant week financial measure basis compared previous year back report information financial performance see 2017 10k revenue growth strategy revenue growth based unmatched pipeline product service global reach diversified market extending existing therapy emerging market represents greatest opportunity business working accelerate growth emerging market public private partnership optimizing distribution channel fy17 revenue emerging market grew 7 percent double digit nongaap constant currency constant week basis economic contribution society 9 return shareholder fy17 56 billion free cash flow nongaap returned 55 billion shareholder net share issuance paid total 24 billion cash dividend rate 172 per share continued included sp 500 dividend aristocrat index marking net sale operating segment business million 39th consecutive year dividend increase revenue growth reported dividend per share fy15 19 6 nongaap fy15 122 fy16 42 7 nongaap fy16 152 fy17 3 fy17 172 3 nongaap 0 5000 10000 15000 20000 25000 30000 dividend payout ratio fy15 30 cardiac vascular restorative therapy fy16 36 cardiac rhythm heart failure spine coronary structural heart brain therapy fy17 39 calculated taking current annualized dividend per share 184 dividing prior aortic peripheral vascular specialty therapy fiscal year nongaap diluted earnings per share pain therapy minimally invasive therapy total payout ratio surgical solution diabetes fy15 55 patient monitoring diabetes recovery fy16 72 fy15 based medtronic fiscal year reported reflects onequarter contribution fy17 86 covidien transaction closed jan 26 2015 figure represents comparison prior year constant currency constant week basis payout ratio fy16 fy17 include contribution 5 billion incremental share repurchase commitment calculated taking current annualized dividend per share 184 dividing prior fiscal year nongaap diluted earnings per share economic contribution society 10 compensation wage expenditure investing talent manufacturing commercial rd make investment infrastructure manufacturing capability operation globally fy17 91000 employee technology allow u grow business fy17 capital approximately 160 country possible hire develop local expenditure totaled nearly 13 billion talent leading job creation community near operation capital expenditure million spent 85 billion total compensation fy17 including 50 billion addition property plant equipment direct salary wage additional 602 million retirement benefit fy15 571 employee compensation million fy16 1046 fy15 fy16 fy17 total compensation 5614 8057 8486 fy17 1254 salary wage 3169 4634 5006 retirement benefit plan 433 584 602 operating cost expenditure essential running business employee 85000 88000 91000 expense also enhance economic contribution amount based actual exchange rate positive impact society instance community operate total compensation includes salary wage incentive overtime severance pay payroll tax benefit salary wage research development rd retirement benefit auto allowance benefit fy15 compensation data contained table represents medtronic operation excluding outlay sale general administrative expense tax covidien however employee data period includes covidien fy16 contained 53 week year contain 52 week medtronic expense million tax also contribute community country operate fy15 tax pay include income real estate sale use payroll excise valueadded tax fy16 fy17 578 million income tax provision resulting 162 percent nongaap nominal tax rate gaap basis global fy17 effective rate 126 percent 0 5000 10000 15000 20000 25000 30000 income tax cost product sold selling general administrative research development fy15 based medtronic fiscal year reported reflects partialyear contribution covidien transaction closed jan 26 2015 includes following expense interest expense net amortization intangible asset acquisitionrelated item certain litigation charge net restructuring charge net special charge gain economic contribution society 11 acquisition investment divestiture support business growth investing development appropriate divestiture provide opportunity refocus market product service also seek opportunity strategic business portfolio strategic priority july 29 2017 acquisition investment help u enhance role completed sale patient care deep vein thrombosis healthcare leader nutritional insufficiency business 61 billion cash business located within patient monitoring recovery approach acquisition division minimally invasive therapy group included 17 dedicated manufacturing facility pursue acquisition bring new technology strategic skill capability expertise medtronic approach aligns strategy provide broad range therapy restore patient health financial assistance extend life positive clinical outcome target firm government agency stakeholder group occasionally provide support core growth strategy therapy innovation economic financial incentive including tax relief tax credit grant value globalization produce strong financial return direct incentive include subsidy benefit award financial specifically look tuckin acquisition deliver midteens incentive aim attract support longterm investment specific riskadjusted return demonstrate clear economic value region disease state align medtronics business strategy business acquisition fy17 included heartware international inc august 23 2016 cardiac philanthropy vascular group acquired heartware international inc heartware philanthropic effort alongside product core business heartware develops manufacture miniaturized implantable heart mission aim expand access healthcare build healthy pump treat certain population patient suffering advanced community globally heart failure total consideration transaction approximately 11 billion fy17 donated approximately 19 percent pretax profit manage philanthropic contribution corporate smith nephew gynecology business august 5 2016 charitable giving business division medtronic foundation minimally invasive therapy group acquired smith nephew see next page information medtronic foundation gynecology business expands strengthens minimally available invasive surgical offering complement existing global gynecology business total consideration transaction disclose donation made u customer organization approximately 350 million affiliated annually charitable donation registry view guideline governing philanthropic contribution approach investment business see charitable donation guideline addition making acquisition invest infrastructure capability learn medtronic product donation see access initiative within existing business accelerate pace breadth innovation enables u gain competitive advantage enhance benefit patient example fy17 invested new nonintensive diabetes therapy ndt facility plymouth minnesota serve global headquarters ndt dedicated team focus product development addressing type 2 diabetes economic contribution society 12 rhd action launched fy16 aim cultivate global movement philanthropy million end rheumatic heart disease rhd vulnerable population fy15 fy16 fy17 led coalition core organization initiative seek unite empower global rhd community sharing technical advice medtronic foundation giving 470 482 400 advocacy support policy insight fy17 rhd action focused corporate cash contribution 313 496 434 effort uganda decentralize screening diagnosis improve referral strengthen capacity existing medical facility product donation 115 168 168 treat rhd also assessed need inform expansion volunteering 16 program tanzania fy18 philanthropic contribution 19 23 19 percentage global pretax profit community wellbeing fy15 include legacy covidien data medtronic foundation provides health access grant underserved significant increase corporate cash contribution product donation fy15 fy16 result population community employee significant covidien integration calculated hourly rate 2356 provided independent sector fy17 first year tracked presence twoyear grant awarded organization value volunteering expand access healthcare people chronic disease address persistent emerging health challenge build partnership medtronic foundation global health program promote collaboration fy17 foundation distributed grant worth global health program medtronic foundation aim total 51 million 40 organization 37 community establish sustainable healthcare solution community around around world world global health program focus increasing access healthcare underserved population working local global partner disaster relief grant foundation help fund emergency healthcare wake crisis support rebuilding damaged fy17 foundation contributed three flagship program infrastructure long term medtronic also provides product donation support disaster relief effort encourages employee donate heartrescue applies best practice reduce premature mortality fund volunteer time acute cardiovascular event best serve unique need community program combine localized patient empowerment engagement frontline health worker policy advancement disaster relief million fy17 u heartrescue consortium expanded 16 state covering nearly 80 million people heartrescue china heartrescue fy15 fy16 fy17 india completed second year fiveyear international expansion medtronic foundation 06 08 07 project plan also way establish program brazil disaster relief healthrise aim enable accurate diagnosis successful fy15 include legacy covidien data management diabetes cardiovascular disease underserved population program enhances care provision working frontline health worker improving efficiency referral system empowering patient selfmanagement strategy fy17 healthrise addressed barrier care community brazil india south africa united state economic contribution society 13 promoting volunteering encourage employee participate medtronic foundation employee community engagement philanthropic effort volunteering employee giving fy15 fy16 fy17 kick new fiscal year monthlong volunteering drive project 6 project 6 encourages employee get involved local community fy17 nearly 15000 employee 48 country volunteer 8880 19800 14900 volunteered total approximately 62000 hour five team total volunteer hour 29000 64800 62000 highest participation greatest impact unique approach 10000 grant medtronic foundation chosen charity country 35 44 48 employeeled project 274 512 462 foundation also donates fund nonprofit every 25 hour individual employee volunteer throughout year volunteer grant 1000 employee participated fy17 raising 500000 volunteer grant 786 968 1106 medtronic foundation match employee contribution volunteer grant raised 515000 484000 553000 approved charity dollarfordollar global matching grant fy17 employee donated approximately 14 million leading global matching grant total contribution 27 million matched employee contribution million 243 149 142 foundation bakken invitation award recognizes individual medtronic match million 20 174 131 help medical technology overcome health challenge fy15 include legacy covidien data give back community fy17 award honored 15 decrease number volunteer volunteer hour fy16 fy17 primarily result significant individual seven country inspiring story read online campaign around volunteering integration covidien fy16 leading increased participation covidien data period januarymarch 2016 included fy16 employee contribution full fy16 covidien data included due timing covidiens integration medtronic workday system foundation held 21 matching campaign fy16 resulting greater dollar amount matched employee donation medtronic match made 11 basis 500 result match amount employee contribution economic contribution society 14 value society priority 15 access medical technology therapy essential tool annual rd spending treatment noncommunicable disease core business delivers positive outcome patient invests new fy15 fy16 fy17 solution unserved health need rd spend million 1640 2224 2193 lack healthcare infrastructure limited resource mean fy15 based medtronic fiscal year reported reflects partial year contribution covidien essential care treatment inaccessible million transaction closed jan 26 2015 people aim create wider access quality affordable healthcare business model focus improving patient introducing new product outcome reaching people taking account many new product therapy designed treat patient economic reality specific market directly enabling positive health outcome better quality life demonstrating value new product making others use data help physician provide better guidance support effective management specific condition widely accessible growing business delivering mission improve health outcome people around world new product therapy data platform launched fy17 include micratm transcatheter pacing system miniaturized pacemaker therapy innovation 93 percent smaller conventional counterpart implanted continued investment research clinical trial delivering noninvasive procedure selfcontained within heart innovative new therapy improve patient life micra approved use united state fda april 2016 minimed 670g insulin pump world first hybrid closedloop research clinical trial system selfadjust help keep sugar level range robust innovation pipeline critical success global research fda approved use united states2 development rd prioritizes unserved health need including stealthstationtm s8 advanced surgical navigation system condition disproportionately affect people emerging market combine hardware software tracking algorithm image data take promising innovation clinical trial establish merging specialized instrument help guide surgical safety effectiveness procedure received fda 510k clearance march 2017 fy17 invested 22 billion rd 74 percent net sale fy17 medtronic became first company receive fda approval launched 75 new clinical trial read responsible approach suite cardiac device lead able scanned clinical trial product quality 3 15 tesla magnetic resonance imaging mri machine patient using device receive mri scan part body may possible previously 2 minimed 670g insulin pump indicated type 1 diabetes patient age 14 prescription required warning may safe child age 7 requiring less 8 unit insulin per day selfadjusts refers auto mode function user interaction required individual result may vary detailed boxed warning important safety information see access 16 read product receiving fda clearance approval follow proprietary sevenstep vbhc framework ensure develop ce mark approval fy17 medtronic newsroom valuebased business model built around clear measurable patient outcome fy17 created new data science function facilitate addition focus innovation also invest collaboration within outside medtronic developing enterprisewide acquire medical technology company expand offering data system support vbhc initiative patient read partnership acquisition economic contribution society many condition treatment opportunity improve patient outcome reduce cost time example type 1 diabetes cost healthcare system around world billion dollar economic value every year nearly 500000 child age 15 globally live continually look efficiency improve affordability type 1 diabetes longterm complication include kidney disease product therapy enhance economic value across global amputation stroke healthcare system includes offering variety pricing model volume pricing rebate option hospital adaptive pricing diabeter clinic network based netherlands offer solution treating longterm condition range program assist new improving patient outcome reducing cost using vbhc model existing patient pursue efficiency gain tandem improving diabeter clinic currently best performing kind effectiveness intervention number patient achieving country 55 percent patient age 18 achieving target positive health outcome blood glucose concentration diabeter also achieves lower rate hospitalization among clinic patient leading reduction direct annual patient cost 86 percent valuebased healthcare majority current healthcare system base payment volume experience program diabeter inform continued procedure performed traditional payment delivery model development vbhc model wide range treatment produced treatment cost unsustainable many healthcare system believe must fundamental shift way managed service healthcare delivered globally toward valuebased healthcare vbhc medtronic integrated health solution form relationship vbhc system payment product service based healthcare provider around world helping achieve ability improve patient outcome relative cost mean goal access cost highquality care administer unit sharing direct accountability delivering meaningful result facility clinic behalf focus catheterization lab hospital operating room benefit include increase lab capacity leader across business division region function 25 35 percent including clinical healthcare economics policy reimbursement legal expert comprise global vbhc council launched january 2016 fy17 formed collaboration university hospital cleveland council responsible accelerating vbhc vision deepening united state define new model efficient outstanding knowledge facilitating sharing best practice within medtronic care delivery catheterization electrophysiology laboratory direction global vbhc council establishing uh cleveland medical center key focus increasing lab capacity council within region local knowledge action creating optimized environment clinical staff focus care delivery medtronic help implement advancement also provides onsite staff manage nonclinical operation scheduling developing valuebased model material management room turnover investment innovation essential achieve shift vbhc system creating new business model enable u take lead driving industrywide transformation access 17 telehealth stateoftheart hub hospital center offering specialist enabling patient require longterm care stay home rather intervention highly trained physician spoke consist admitted healthcare facility improve quality life increase healthcare center surrounding community together offer service efficiency reduce cost 2016 study showed monitoring complete coordinated care improved patient convenience patient remotely yield saving 8375 per patient year3 economy scale welldefined patient pathway referral system important part model patient pathway innovation approach medtronic care management service provides remote monitoring system offer systematic way characterize current care pathway identify patient chronic condition followup acute care barrier access develop workable solution given location admission surgical procedure mobile tabletop monitoring platform result set consistent highquality diagnostic treatment collect biometric symptom data triggering clinical review necessary protocol clearly supported clinical evidence patient access patient advocacy support service need additional advice experienced staff member currently offer fy17 part hub spoke approach continued work 20 different program patient single multiple disease abraaj capital global healthcare fund work focus improving healthcare access primarily africa indian subcontinent fy17 launched beacon new service highrisk heart failure reducing gap supply demand health service patient medtronic icd cardiac resynchronization therapy addition medtronic entered several new hub spoke partnership crt device combining data patient device symptom variety health system organization including private equity biometrics beacon enables provider evaluate early intervention firm academic startup developing innovative healthcare patient risk heart failure solution deploy hub spoke model africa expanding global access medtronic lab continually look new way expand treatment presence removing barrier healthcare access reducing health inequality serve people place around world rather taking emerging market requires understanding local context priority single global approach develop solution reflect market need medtronic lab response challenge launched fy17 enables u tailor access initiative suit specific infrastructure evolution global health initiative seek deliver financially economics health priority given location sustainable business structured impact scale medtronic lab draw expertise knowledge employee develop locally certain emerging market employ hub spoke strategy appropriate business model provide ambitious idea expanding increase efficiency accessibility care see underserved healthcare access population market disparity healthcare need access greatest develop solution initiative one medtronic lab program akoma pa aim help patient medtronic lab outlined right clinician subsaharan africa manage hypertension efficiently ghana nearly 30 percent population hypertension yet read medtronic foundation global health program 28 percent affected control adequately philanthropy pharmacological management lifestyle modification akoma pa offer enhanced management access treatment combining proprietary hub spoke model mobile application support local pharmacist clinician hub spoke model healthcare delivery designed maximize providing tailored management plan novel model offer significant efficiency improve patient access resource limited opportunity reduce burden chronic care management clinician model offer strategic approach healthcare infrastructure patient health system based learning akoma pa plan efficient integrated system designed support longterm health roll wider hypertension program empower health fy18 care need 3 home pilot study undertaken geneia access 18 understanding access need china collaborating chengdu municipal government access initiative appropriate effective must invest manufacturing facility stateoftheart diabetes understand evolving patient need market opportunity management technology aim expand access essential patient access acceleration paa methodology intervention growing number people diabetes china consistent approach identifying tackling access need nearby country location paa includes four step capacity building quantify treatment need simply expanding patient access product therapy identify barrier care enough deliver transformative change local infrastructure need support effective intervention healthcare provider patient prioritize barrier care must skill knowledge offer understand specific formulate strategy tackle barrier treatment option patient access solution pa consulting service partner hub spoke model described create capacity hospital around world identify access need barrier healthcare system developing infrastructure investing skill implement appropriate local solution fy17 pa group completed healthcare professional also partner local healthcare provider 10 consulting engagement three country focused activity deliver infrastructure change medtronic integrated health asia pacific region enabling u build intensive expertise solution see managed service integration local healthcare service within single region fy17 invested 1397 million capacity building training medical professional 226 million patient education specific partnering others activity included collaboration essential component effort reach launch medtronic impact europe middle east africa patient around world partner range stakeholder region part drive toward vbhc model introducing tackle access need including novel approach healthcare education development medtronic healthcare provider well governmental nongovernmental impact extends beyond traditional product procedure training organization enhance ontheground delivery offering extensive range topic entire spectrum healthcare professional online offline program developed peer company develop new technology therapy delivered network collaboration worldclass university academic promote thought leadership healthcare institution ambition medtronic impact reach research 500000 healthcare professional next five year cardiovascular disease cause death russia chronic enhancing clinical training africa partnership stellenbosch disease yet 7 percent affected patient receive stent year university south africa launched new clinical training laboratory fy17 partnered renova group russia leading private healthcare professional lab offer realworld training business group establish new joint venture known stentex joint environment cuttingedge procedure including use high venture aim enable local production medtronic catheter balloon definition surgical microscope imageguided navigation equipment stent treatment acute coronary syndrome potential keyhole surgery endoscope facility host professional support thousand patient lifesaving intervention across africa capacity train 1200 people first year alone access 19 medtronic innovation center mics mic training center offer specialist facility healthcare professional enhance knowledge skill center shanghai china hosted nearly 7000 physician training session surgical technique osong south korea delivered training 1000 physician including program trainee surgeon gain handson experience medtronic technology product capacity building patient access solution pa pa group examines capacity part consulting engagement fy17 pa intervention resulted development tool identify patient group needing better access kazakhstan well improved clinician capacity facility australia partnership world stroke organization wso continued partnership wso developed new program focused increasing stroke awareness among patient healthcare professional sponsored wso road map quality stroke care provides guidance stroke care local healthcare provider clinical group also collaborated wso delivery awarenessraising activity china india healthcare capacity building fy15 fy16 fy17 education medical professional 1088 1524 1397 million education patient million 187 203 226 medical professional reached 50796 64233 52193 excludes mitg patient monitoring recovery business product donation improve patient access essential treatment made 168 million product donation fy17 read economic contribution society access 20 product quality patient rely product safe effective deploy medtronics global quality supply management strategy control every stage value chain clinical research support business strategy postmarket analysis patient physician confident quality deliver reinforce commitment product business strategy need quality imperative quality regular training employee supplier responsibility quality therapy product effective mindset protect patient health unwavering focus product innovation superiority efficient excellence compliance excellence commitment quality help u effectively treat patient providing product complying ingraining proactive patientcentric reduce reputational risk maintain trust business improve highest quality applicable quality culture reliability regulation quality talent operational efficiency efficiently management patient heart global quality strategy program supplier supply management imperative designed ensure medtronic product high quality globalization partner safe expect people take individual responsibility demonstrate leadership quality culture quality training communication quality functional supplier service excellence performance focus one key message quality begin reinforcing four excellence optimized create fundamental behavior expectation economic proactive supplier scalable process competitive value engagement capability advantage put patient first courageous strive prevent issue arise hold accountable fy17 extended quality begin training 200 supplier also help supplier build system capability align quality requirement see responsible supply management information product quality 21 employee worldwide complete annual quality training certification assess quality management system global compliance focus product quality regulatory compliance good oversight program medtronic corporatewide assessment regulatory documentation practice continual improvement fy17 excellence mcare help u maintain consistent quality 97 percent employee completed training regulatory compliance across business enhance readiness comply new regulatory requirement fy17 assessed design reliability manufacturability drm program integrates safety implemented improvement 40 facility mcare quality reliability throughout product development process engineer simulate product used real world better understand predict performance first time quality ftq maintaining quality facility methodology train manufacturing employee see potential error develop strong control identify improvement fy15 fy16 fy17 biggest impact product quality external regulatory inspection 168 244 284 use medtronic operating system mo embed quality medtronic site globally production applying lean six sigma principle teambased system external regulatory inspection 92 89 93 achieving continual improvement also use leading international globally resulted finding standard medical device quality system management iso 13485 average finding per external 018 030 018 fy17 expanded drm mo ftq process new regulatory inspection product development manufacturing site also expanded supplier quality initiative rolling training ftq program average finding per fda inspection 048 144 073 contract manufacturer supplier mcare assessment 28 37 40 supported improvement maintaining quality facility number restated 2015 integrated report due inclusion regional inspection number restated 2016 integrated report due internal validation process identified external regulatory agency review monitor performance missing inspection quality compliance regulation every year assessment help u better understand regulatory priority identify area enhance policy procedure process product use performance share learn across business inspection monitor performance product use collect data knowledge management process implement improvement quality patient outcome postmarket surveillance facility worldwide capture critical data product postapproval clinical fy17 284 regulatory inspection medtronic site surveillance process draw network partner hospital health 93 percent resulted finding goal maintain system physician clinic government thirdparty database average 05 fewer finding per inspection fy17 achieved process cover north america europe latin america continues goal average 018 finding per inspection expand business grows subset inspection conducted fda received medtronic also fund indepth postmarket clinical study specific 073 finding per inspection meeting goal 10 fewer finding therapy product line support improvement per u fda inspection product quality 22 enhancing postmarket surveillance fy17 fda class recall medwatch safety alert product list postmarket surveillance help u fulfill commitment prioritize medtronic device patient outcome offer valuebased healthcare collaborate global regulator industry stakeholder enhance postmarket fda class recall 1 pipeline classic marathon surveillance technique method ultraflow xcelerator 1900 clinical professional across medtronic work develop 2 heartware ventricular assist device hvad system controller standardize model measure improve patient safety clinical outcome exploring new method obtain valuable information 3 ht70 ventilator enabling product use lower cost without compromising quality 4 stratamr regulatory compliance 5 synchromed ii bolus priming software card collaborate customer help improve product service collect manage feedback using global complaint fda medwatch 1 stratamr adjustable valve shunt handling system safety alert 2 capnostream 20 patient monitor human medical battery pack product database productrelated regulatory action 3 capnostream 20p patient monitor implement corrective action swiftly effectively regulatory battery pack field safety issue identified including initiation voluntary product 4 synchromed ii synchromed el recall aim understand remedy root cause problem implantable drug infusion pump system place prevent recurrence 5 medtronic neurovascular product fda classifies product recall numerical designation ii iii fda issue medwatch safety alert provide public new safety information product indicate relative degree health hazard class serious includes action classified recall fda fy17 five medtronic product subject class recall see table detail nature recall found fda list clinical trial device recall website clinical trial test safety efficacy product go product use performance market committed conducting clinical trial accordance relevant law regulation code conduct global fy15 fy16 fy17 business conduct standard policy clinical trial principle also committed following international guideline clinical research open fda consent decree 1 1 1 international conference harmonization world health organization productrelated regulatory action good clinical practice standard iso 141552011 open fda warning letter 3 1 2 productrelated regulatory action open fda warning letter 2 0 1 resolved year fda class recall 6 4 5 product quality 23 collaborate organization working advance development preclinical research clinical standard support related educational engagement regulatory requirement sometimes necessitate animal research see table testing product 30 year medtronic leader pioneering innovative approach reduce use animal clinical standard development education engagement medtronic senior principal scientist mike wolf worked diligently develop innovative animalfree alternative blood interaction test organization fy17 half medtronics product come contact patient blood clinical trial senior vice president chief scientific consequently iso 109934 standard blood interaction testing transformation clinical regulatory officer serf key guideline preclinical evaluation device due initiative ctti ctti executive committee effort revised iso 109934 standard published april 2017 includes new nonanimal testing method serf medical association medtronic involved aamis u device industry global guidance document selection blood advancement international work employee participate interaction test medical 120 aami committee working instrumentation group hold 11 leadership position including important international validation study alternative animal aami rotating chair board director testing skin irritation completed fy17 original research international medtronic maintains active presence put forward distinguished medtronic toxicologist kelly medical device imdrf subject matter expert serve coleman followup validation study conducted 20 lab regulator forum industry representative imdrf initiative sponsored iso technical committee confirmed synthesized imdrf also supported participated pilot human skin acceptable replacement existing rabbit skin imdrfs medical device single audit program irritation test finding study submitted fy18 support planned iso 10993 standard human skin cellbased medical device chief medical officer serf board irritation testing innovation director mdic publicprivate partnership consortium mdic aim advance regulatory science policy regarding use animal requires animal medical device industry used research activity acceptable alternative includes research contributes significantly patient welfare transparency open data well work specifically mandated regulatory agency order ensure patient safety efficacy activity conducted sharing data clinical trial help medtronic broader scientific approval institutional animal care use committee community deliver benefit patient long term also support commitment maintaining patient safety scientific necessary use animal research committed integrity performing clinical trial treating respectfully humanely taking every measure safeguard welfare includes minimizing pain suffering distress publicly disclose information clinical trial required harm work scientist veterinary surgeon expert clinical trial registry available clinicaltrialsgov registry refine trial develop best possible approach result database detail purpose eligibility requirement location status applicable clinical trial sponsor also publish committed meeting relevant standard requirement finding peerreviewed scientific medical journal collaborate animalrelated research testing set association external researcher institution assessment accreditation laboratory animal care fda u department agriculture animal welfare act product quality 24 product stewardship pacemaker insulin pump product improve packaging design innovation save patient life product offer clear benefit sourcing sustainable packaging material cutting overall packaging people society manufacture use disposal need reduces environmental impact production cost waste impact environment work minimize product fy17 launched sustainable packaging working group environmental impact reducing energy resource used establish process program promote assess measure waste created every stage product lifecycle sustainability packaging design fy18 aim refine sustainable packaging guideline identify target track progress sustainable packaging project across business approach customer increasingly expect u demonstrate strong product endoflife management stewardship across lifecycle environmental health safety sustainability ehss program require implementation important part product stewardship strategy understanding product stewardship initiative throughout medtronic helping u better managing reducing impact product end usable life meet expectation aim capture value used product divert landfill reduce environmental footprint product start fy17 sustainable technology business diverted 308 engineer scientist started incorporating ehss guideline metric ton mt used medical device nellcor business alone research develop design new product consider collected recycled 2700 mt used medical sensor environmental impact related manufacturing material used would otherwise gone landfill reclamation product packaging product reach end program collected 54 mt precious metal usable life reclaim material reuse possible gold silver platinum titanium palladium product like pacemaker defibrillator neurostimulators monitor regulatory change globally implement practice comply applicable local regulation including european union directive restriction hazardous substance rohs registration evaluation authorization restriction chemical reach california proposition 65 fy17 began transitioning compliance european union new medical device regulation mdr replace previous medical device directive active implantable medical device directive product stewardship 25 responsible supply management mission support culture citizenship purpose supplier quality management responsibility hold accountable promote human healthcare partner patient expect u deliver flawless product right environmental stewardship ethical behavior therapy product quality critical reputation future extend expectation supplier success achieve highest quality standard focus operation see product quality also management supplier integral delivery product therapy supplier technology need improve patient outcome maintain quality reliability supply chain aim forge longstanding provide protocol tool training support help supplier meet relationship supplier share commitment high standard quality standard including 73000 supplier 129 country fy17 spent continuous improvement opportunity training development nearly 12 billion supplier globally participation design reliability manufacturability drm process ensures standardized product performance supply chain spend million supplier quality excellence manual supplier required fy15 fy16 fy17 follow australia 549 527 737 fy17 medtronic recognized gartner healthcare supply chain canada 774 1398 1490 top 25 acknowledgment leading company demanddriven supply chain management china 1432 2525 2819 france 933 2475 1856 information manage quality finished product see supplier quality website germany 1609 2333 2200 ireland 1535 1951 2059 responsible supply management israel 103 175 211 expect supplier contractor behave ethically abide japan 1007 1380 1649 applicable law uphold human right worker ensure safe mexico 552 1280 1519 healthy working environment use environmentally responsible netherlands 1297 1799 1849 practice mission responsible supply management program singapore 314 938 1269 uphold human right labor standard supply chain switzerland 1396 1806 1911 united state 47553 82568 84987 reduce environmental impact globally locally total location listed 59054 101155 104556 enhance medtronics reputation total spend 67079 115435 119275 responsible supply management 26 fy15 include legacy covidien data fy17 introduced global supplier standard outline minimum conflict mineral social ethical environmental requirement supplier must u doddfrank act requires company disclose use comply standard become part selection criterion conflict mineral originating democratic republic congo new supplier fy18 begin monitoring compliance neighboring country proceeds mining linked standard initial focus supplier highrisk country case armed conflict support work comply regulation serious noncompliance standard reserve right detailed conflict mineral policy terminate supplier contract mineral covered regulation used product agent contractor working medtronic must comply expect supplier comply law uphold responsible sourcing medtronic global code conduct investigate reported violation practice reference conflict mineral requirement supplier take appropriate action necessary including terminating agreement purchase order term condition also perform agreement contractor addition global human right annual due diligence following oecd guidance conflict mineral labor standard policy applies medtronic supplier service provider including surveying supplier collecting data including thirdparty labor agency business partner participate industrywide forum conflict mineral responsible supply management best practice integrated ethical sourcing forum marcus evans conflict mineral conference purchasing decision train supply management team work conflictfree sourcing initiative conflict mineral program leader supplier help improve labor standard fy17 launched julia litvak named 2017 top 100 conflict mineral influence expanded labor standard assurance system better monitor leader assent compliance independent compliance service firm labor issue within operation supplier medtronics fy17 conflict mineral report published sec website track many core supplier produce sustainability report indicator public commitment social environmental responsibility fy17 survey found 34 percent top 208 supplier diversity supplier produce sustainability report 10 percent publicly state committed supporting diverse supplier including small sustainability goal website continue monitor core business well business owned woman minority lgbt supplier encourage make public sustainability commitment member veteran people disability commitment information supply chain policy procedure set u supplier diversity policy fy17 approximately best practice see responsible supply management website 35 percent u supplier spend small diverse company also encourage tier 1 supplier track report spend diverse business material concern material concern used product packaging supplier diversity team supplier diversity steering committee require supplier manage responsibly line regulatory executive management team oversee supplier diversity program requirement european union directive restriction promote inclusive sourcing employee training business unit hazardous substance rohs registration evaluation authorization annual plan sponsorship organization develop promote restriction chemical reach california proposition 65 small diverse supplier u fy17 99 percent sourcing see product stewardship supply chain management team u completed supplier diversity elearning training medtronic recognized diversityincs 2017 top 50 list honoring leading company support workforce diversity inclusion management supplier diversity responsible supply management 27 u diverse supply chain spend category million fy15 fy16 fy17 u u u u u u spend spend spend spend spend spend small business 1102 299 21229 325 17969 281 veteranowned business 497 14 826 13 791 12 minorityowned business enterprise 1490 40 1928 30 2790 43 womenowned business enterprise 831 23 1237 19 1390 21 diversity table includes u addressable spend fy17 addressable spend approximately 63 billion exclusion total employeerelated benefit health insurance tax royalty others fy15 data prior covidien acquisition responsible supply management 28 ethic sale marketing earning confidence stakeholder partner key training also part orientation process individual joining continued business success maintain trust must medtronic senior leader highrisk role honest transparent product information must also distributor dealer certain third party also complete eliminate potential conflict interest employee anticorruption training support monitor thirdparty distributor healthcare professional sale marketing activity working behalf distributor compliance program fy17 launched new distributor code conduct trained guiding policy principle 93 percent distributor code entering renewing global business conduct standard policy contract conduct due diligence assess potential corruption includes global anticorruption policy contract require distributor implement anticorruption program market expanding direct sale code conduct infrastructure reduce reliance thirdparty distributor decrease code ethic senior financial officer risk corruption improve customer service code business conduct ethic approximately 220 expert fulltime equivalent support compliance member board director anticorruption policy worldwide also consult regulator medtronic donation anticorruption measure employ several former u department justice prosecutor leadership role medtronic ethical business conduct fy17 medtronic subject fine settlement related medtronic code conduct related policy inform way noncompliance anticorruption law interact healthcare professional market product office ethic compliance oversees monitor implement countering corruption accompanying policy program fy15 fy16 fy17 countering corruption employee supporting anticorruption effort 223 223 220 conflict interest recognized risk industry eliminating fulltime employee equivalent potential conflict particularly related sale interaction thirdparty distributor receiving 87 88 93 employee healthcare professional priority anticorruption training employee must comply global anticorruption policy thirdparty distributor receiving 64 27 25 global business conduct standard applicable external law onsite monitoring regulation policy procedure mandatory annual training fy15 data include legacy covidien operation restated 2015 2016 integrated report due internal validation process code conduct reinforces requirement customerfacing restated 2016 integrated report due internal validation process employee complete additional anticorruption training every two year ethic sale marketing 29 responsible marketing customer patient customer data security business unit responsible making sure product promoted medtronic relies data make product therapy effective accurately appropriately line industry guideline customer patient expect u keep data secure government law regulation marketing directly healthcare responsibility remains high priority medtronic global security provider follow internal code conduct advameds voluntary office security steering committee oversee security program code ethic interaction health care professional ensuring policy place designed protect information continually look way strengthen program address comprehensive program place help ensure marketing evolving threat including cyberthreats design information practice comply ethical policy external regulation security management control based recognized standard part program monitor thousand transaction annually national institute standard technology iso 27001 sale marketing risk antikickback bribery corruption fy17 updated 24 training module educate employee key tenet security program includes mandatory security training external faculty appropriate product promotion practice medtronic employee contractor special focus subject fine settlement related allegation handle access sensitive data addition medtronic launched improper marketing sale product fy17 medtroniccomsecurity november 2016 disclosure website enables customer physician patient interested party responsible marketing customer patient submit inquiry medical device security matter security team conduct thorough investigation across relevant department fy15 fy16 fy17 respond inquiry product vulnerability number fine settlement 2 0 0 actively engage outside organization third party expert related allegation improper assist u ensuring continuous improvement security program marketing sale product order address evolving threat landscape meet exceed marketing sale employee 13944 14409 14899 external best practice standard include informationsharing trained product promotion body national health information sharing analysis center medical device innovation safety security consortium fy15 data include legacy covidien operation fine noted represent year fine paid regulator government agency customer medical device manufacturer also contribute development product cybersecurity standard globally ethical interaction healthcare professional promote integrated healthcare system working healthcare professional develop innovative solution guiding principle ensure interaction partner founded achieving best outcome patient eliminating potential conflict interest support industry initiative make information payment healthcare professional publicly available disclose payment made physician teaching hospital country required law united state information published u center medicare medicaid service open payment website also comply related regulatory reporting requirement information approach physician collaboration see website ethic sale marketing 30 working responsibly company 31 governance engagement expect employee demonstrate strong diversity leadership help u reflect need varied commitment ethical behavior attitude stakeholder including patient partner employee community action creating ethical workplace culture start twentyfive percent board member woman 25 percent represent minority group board director ceo set companywide expectation strong governance integrity commitment nominating corporate governance committee identifies need integrity underpins interaction external stakeholder replace current member board fill vacancy expand size partner collaborate drive meaningful sustainable board considers candidate variety source including change global healthcare system thirdparty search firm assist identifying evaluating conducting due diligence potential director candidate corporate governance potential candidate evaluated based criterion established medtronic board executive leadership guide approach governance principle criterion include business experience corporate governance transparency practice skill judgment honesty integrity ability commit sufficient time fundamental success business oversee policy attention board activity absence potential conflict procedure support mission safeguard interest medtronics interest additional factor considered include diversity company shareholder ensure employee understand respect background viewpoint skill experience community expected board also deeply involved developing involvement input member board full board corporate strategy responsible reviewing approving chooses nominee considering recommendation medtronics annual strategic plan report nominating corporate governance committee evaluation occurred board director information board director committee charter medtronic board director comprises 12 member including membership visit corporate governance website chairman ceo omar ishrak appointed lead independent director scott donnelly six standing committee independent director executive compensation oversee business operation drive innovation ultimately longterm business success audit must attract talented executive diverse skill background challenge status quo offer competitive benefit alongside cash compensation equity incentive board compensation committee evaluates approves executive compensation read approach nominating corporate governance compensation proxy statement finance financial risk quality technology value creation governance engagement 32 ethical workplace code conduct wellestablished policy practice reinforce culture integrity companywide include ethic compliance system fy15 fy16 fy17 data analytics human resource management look industry employee receiving code conduct 98 98 97 best practice benchmark including ceb track performance training certification peer new employee receiving code 99 99 99 every employee accountable compliance ethic policy conduct training certification guideline manager assess ethical behavior annual performance u employee certified read 100 100 100 review employee meet expectation recognition understood code conduct award monetary bonus may withheld employee terminated ethical 99 125 218 engaging employee ethic compliance compliancerelated infraction fy15 data include legacy covidien operation global code conduct central ethic compliance calendar year 2014 program guiding everyday action interaction internal calendar year 2015 calendar year 2016 external stakeholder increase previous year primarily due expanded definition termination due ethical compliancerelated infraction code available 22 language meaning 99 percent employee read first language also provide multilingual fy17 conducted online survey gauge employee perception training new employee joining medtronic performance ethic compliance response 55000 acquisition fy17 97 percent employee joining acquisition employee revealed well making expectation received compliance ethic training within 90 day transaction clear cultivating open relationship manager survey also identified opportunity improvement encouraging employee employee retrained code conduct year everyone voice thought enabling feel trust colleague medtronic including board member must certify understanding raising concern code requirement annually fy17 introduced specialized ethic training new manager updated training ethic integrity week reinforced importance new employee promote ethical behavior asked employee ethical behavior action activity reached 60 country set personal ethic goal outlining achieve 11 language cardiac vascular group held leadership panel event focused ethic open employee 3500 people attended person virtually watched recording event also launched 100 new ethic circle group worldwide engaging small group employee specific ethical issue one program latin america received medtronic compass award medtronics highest award acting ethic integrity presented ceo program recognized identifying difficult ethical situation employee may encounter suggesting way deal 2100 people joined one 111 ethic circle group across 11 country 4 inbox monitored administrative staff board director pertinent matter brought board attention discussion governance engagement 33 management approach public policy office ethic compliance oec oversees monitor government affair health economics reimbursement implement policy program related legal compliance regulatory affair team lead government engagement activity ethical obligation activity include advocate public policy advance mission business objective including facilitating ethic training running ethic program analytics enable therapy innovation maintaining confidential reporting hotline voice concern line facilitate access lifesaving therapy device leading investigation alleged misconduct generate economic value supporting compliance team leader across organization promote outcomedriven valuebased healthcare developing monitoring program campaign increase employee ethical awareness streamline international regulatory practice reporting quarterly audit committee least annually maintain active membership medical device trade organization full board via chief ethic compliance officer globally including advamed apacmed medtech europe well association many different country u state ceo reporting concern cochairs world economic forum global health healthcare partnership community trustee asia society board encourage employee seek guidance ethical issue raise member usindia business council concern possible legal ethical violation via manager human resource legal compliance representative medtronic complies relevant country state law disclosure oec board director email inbox4 voice concern line political contribution read political contribution policy oec process track oversees reported concern investigation resolution fy17 oec tracked 1200 stakeholder engagement concern approximately 75 percent related workplace engage collaborate broad spectrum stakeholder across conduct remaining concern covered issue accounting anti healthcare system work together overcome industrywide corruption interaction healthcare professional government challenge deliver meaningful innovation improve patient outcome disciplinary action appropriate included coaching change increase global access healthcare job responsibility title primarily demotion discussion performance review serious case dismissal calendar year 2016 total stakeholder include patient physician hospital administrator 218 employee terminated ethical compliancerelated advocacy group government nonprofit nongovernmental infraction see code conduct table previous page organization employee supplier shareholder regulator community operate external ethic compliance issue arise work relevant authority resolve quickly effectively fy17 hosted global medical device security symposium inviting industry expert share insight around product security example stakeholder engagement activity presented throughout report website governance engagement 34 operation medtronic committed operating safe four regional ehss director coordinate local representative environmentally sustainable manner proactive approach throughout company manage ehss program ensure reduces health safety hazard workplace minimizes compliance relevant regulation director oversee operation following region impact operation environment enhances business efficiency drive progress monitor america environmental performance goal reduce energy asia pacific use emission waste water use china management approach europe middle east africa global environmental health safety ehs policy guide approach operating safe environmentally sustainable manner environmental management system requires u facility must meet rigorous ehss standard go beyond comply applicable law regulation corporate national regulation many country operate industry standard medtronic organization held internal ehss management establish ehs goal target measure continually system based principle iso 14001 ohsas 18001 site improve performance greater potential ehss risk environmental management system certified iso 14001 safety system certified integrate ehs business decision ohsas 18001 minimize impact environment internal audit major manufacturing facility office worldwide create safe healthy workplace ensure compliance standard external regulation fy17 site gap assessment helped guide implementation recently communicate policy stakeholder updated ehs standard corporate environmental health safety sustainability ehss participate following external sustainability initiative enhance team oversees program health safety ehs compliance environmental management report performance sustainability environmental management environmental remediation provide training help ehs professional implement cdp climate disclosure performance policy accompanying standard site around world u environmental protection agency smartway transportation partnership sustainable fleet management energy star program energy efficiency operation 35 operational footprint energy use ghg emission environmental priority focused energy use greenhouse recognize risk climate change pose society gas ghg emission regulated nonregulated waste water use business aim reduce carbon footprint operation using less energy less carbonintensive energy source made significant stride toward 2020 environmental performance goal last four year meeting target energy almost emission come use electricity natural use ghg emission nonregulated waste water use see table gas liquefied petroleum gas fuel oil fy17 ghg emission fy17 saw increase rate regulated waste generated totaled 493000 metric ton mt used approximately 128 million working address across operation see managing waste megawatthours mwh energy fy17 5 percent previous year increase fy16 fy17 largely result recent acquisition increased production despite maintained 2020 environmental performance goal overall 15 percent reduction goal energy use compared fy13 fy15 fy16 fy17 change 2020 baseline normalizing increased revenue fy13 goal time surpassed ghg emission goal achieving total fy17 reduction 17 percent compared fy13 baseline normalizing energy use 477 424 438 15 15 increased revenue mwh million revenue energy efficiency ghg emission 185 160 169 17 15 metric ton wherever feasible use energyefficient lighting ventilation system million revenue equipment facility combined automated building control help u achieve significant saving energy use nonregulated waste 747 1645 1318 32 15 emission cost energy conservation project enable u avoid metric ton estimated 25000 mt ghg emission per year cut annual billion revenue operating cost approximately 55 million fy17 implemented regulated waste 91 92 120 48 10 145 energy conservation project globally including extension metric ton energyefficient lighting installation billion revenue water use 128 116 105 23 10 clean renewable energy cubic meter medtronic invests onsite clean renewable energy solar million revenue cogeneration fuel cell technology generated 64000 percentage reduction goal based fy13 baseline year recalculated account covidien mwh clean renewable energy fy17 across 10 site ireland italy acquisition fy15 data reflects medtronic covidien operation restated 2016 integrated report due internal validation process puerto rico south africa united state example newly deployed fuel cell technology northridge california site provide 12400 mwh clean energy annually meeting approximately 60 percent site energy need evaluating additional opportunity renewable clean energy installation site worldwide including two fuel cell planned site north connecticut operation 36 fy17 performance regulated waste material chemical used production energy use comprise less 10 percent overall waste yet fy17 fy15 fy16 fy17 increased 32 percent total 3500 mt primarily due increased manufacturing robust process evaluate address mwh 524000 1224000 1282000 significant waste generator categorize waste type quantity mwh million revenue 296 424 438 concerted effort meet 2020 goal fy16 data reflects january 2015 covidien acquisition prior year data include legacy covidien operation addition managing waste daytoday operation also manage 26 cleanup site globally site identified report ghg emission showing possible release hazardous material eight site united state fall comprehensive environmental response fy15 fy16 fy17 compensation liability act cercla also known superfund metric ton 197000 462000 493000 also look opportunity increase recycling product metric ton million revenue 111 160 169 reclamation reuse information example see product stewardship fy16 data reflects january 2015 covidien acquisition prior year data include legacy covidien operation fy17 energy conservation fy17 performance energy conservation project 145 nonregulated waste energy conservation saving mwh 49000 fy15 fy16 fy17 ghg emission avoided mt 25000 metric ton 13277 47456 38567 operating cost saving million 55 metric ton billion revenue 747 1645 1318 saving energy rebate million 18 fy16 data reflects january 2015 covidien acquisition prior year data include legacy covidien operation restated 2015 integrated report due internal validation process restated 2016 integrated report due internal validation process managing waste regulated waste strive avoid waste generation minimize environmental impact reduce cost landfill diversion initiative include cutting amount fy15 fy16 fy17 scrap produced manufacturing making office paper free metric ton 1714 2659 3500 composting food waste cafeteria sixty percent waste generated recycled fy17 metric ton billion revenue 97 92 120 fy16 data reflects january 2015 covidien acquisition prior year data include legacy covidien operation reduced amount nonregulated office cafeteria waste restated 2015 2016 integrated report due internal validation process generated facility 19 percent fy17 approximately restated 2016 integrated report due internal validation process 38600 mt achieved 2020 goal reduce nonregulated waste intensity 15 percent twice total reduction 32 percent compared fy13 baseline operation 37 recycling fy15 fy16 fy17 metric ton 7667 28207 25435 recycled 51 56 60 fy16 data reflects january 2015 covidien acquisition prior year data include legacy covidien operation restated 2015 integrated report due internal validation process water although operation consume significant amount water recognize importance water local community ecosystem aim minimize water use improving efficiency production process landscape irrigation system heating cooling system fy17 used approximately 31 million cubic meter water worldwide 8 percent less previous year surpassed 2020 goal reduce water use intensity 10 percent fy13 baseline achieving 23 percent reduction overall fy17 performance water use fy15 fy16 fy17 cubic meter 1240867 3340321 3070925 cubic meter 70 116 105 million revenue fy16 data reflects january 2015 covidien acquisition prior year data include legacy covidien operation restated 2015 integrated report due internal validation process restated 2016 integrated report due internal validation process operation 38 employee talented dedicated workforce help u grow business learning development solving pressing medical challenge improve life following employee orientation individual join company patient worldwide part mission recognize offer continued learning development opportunity throughout valuable contribution employee make work career medtronic advance personal professional growth learning 570 online learning tool course available including development opportunity virtual inperson workshop webinars elearning opportunity many supporting tool resource exist performance global workforce career development portal aligned career development end fy17 medtronic employed 91000 people framework believe offering education also operated approximately 160 country year hired differentiated exposure opportunity experience continued 17000 new employee career growth fy17 invested 76 million employee training development program data summary provides detailed data workforce leadership development program help ensure leader equipped skill needed effectively manage develop investing workforce team fy17 launched several new program set consistent invest talent management leadership development program expectation medtronic leader enhance skillsets enhance expertise productivity employee enable leadership program include achieve personal goal enrich assisting new manager building essential leadership skill performance career development 1000 manager participated since start program june 2017 fy17 medtronic launched new global performance career development process process made three required elevate nominationbased development program high conversation annually employee manager ensures potential leader designed accelerate skill strengthen employee opportunity discus career aspiration leadership pipeline across organization fy17 set goal review performance manager regularly 200 highpotential manager senior manager graduated integrated approach support clear consistent performance career program management across company also establishes robust framework career development differentiated pay based result vice president onboarding program support leadership behavior demonstrated pursuit high performance successful transition vice president new medtronic promoted vice president position first time investment career development performance management aim familiarize business team also extends supply chain manufacturing direct labor population expectation associated role fy17 unique need follow local process ensure effective annual 80 people participated performance appraisal process employee 39 employee engagement workforce diversity raceethnicity engage employee gather valuable feedback experience medtronic fy17 75000 employee took fy15 fy16 fy17 part employee engagement survey strong response rate minority representation united 30 33 33 82 percent overall engagement score 74 percent higher state excluding puerto rico industry average 65 percent performed well area support mission creating opportunity woman contribution patient safety opportunity improvement include fy17 woman made 344 percent management position facilitating reasonable risktaking innovation providing employee globally represented 47 percent new hire opportunity share voice see meaningful action result feedback medtronic womens network support gide team improving ability attract retain advance woman employee engagement survey manager receive baseline metric 9000 woman part network operates 90 hub 32 insight help identify area strength opportunity country fy18 plan launch wise program specifically improvement work team develop action plan encourage woman join science engineering role encouraged share responsibility progress throughout year employee resource group inclusion diversity 14000 employee take part 13 grassrootsdriven employee embrace diversity key differentiator accelerator innovation resource group erg 32 country erg unite around common business performance ceo executive committee board identity help foster inclusive culture across business director advocate inclusion diversity quarterly partner gide team support recruiting development review diversity network leadership team twentyfive percent community involvement effort related focus board member woman 25 percent represent minority group fy17 received external recognition inclusive diverse global inclusion diversity engagement gide team lead culture including effort promote diversity create inclusive workplace human resource process priority team provides analysis achieving perfect 100 percent score eighth consecutive year strategic support help leader drive measurable progress human right campaign corporate equality index diversity network aim accelerate career woman globally rising four spot diversityincs top 50 company diversity ethnically diverse leader united state also influencing ranking 46 1800 participating company key business strategy meet healthcare need population named asia society best employer promoting asian represent four diversity network global medtronic pacific american woman best employer marketing support womens network african descent network hispanic latino asian pacific american community descent network asian descent network executive committee member support diversity network providing executive sponsorship including advocating resource change across organization 2020 aspiration woman represent 40 percent manager globally also aspire ethnically diverse talent represent 20 percent role management united state employee 40 employee compensation proactively reduce injury risk reporting significant incident management publishing safety alert focusing specific program offer competitive compensation package based individual site higher number injury example certain manufacturing business performance well industry benchmark local system incorporated ergonomic review ergonomic playbook market information executive compensation see governance expand playbook fy18 include variety environmental engagement health safety sustainability ehss consideration benefit valuable part medtronics total reward package engage operation executive quarterly review health benefit flexible affordable competitive within industry safety performance business group regional level fy17 benefit vary country comply relevant national regulation achieved 6 percent improvement recordable incident rate typically include compared previous year workrelated fatality health dental vision coverage employee addition rolled 18 updated ehss standard fy17 eligible dependent provided corresponding training ehss representative globally retirement plan also provided site representative gap assessment tool evaluate site performance opportunity ongoing improvement fy18 life disability insurance internal audit program continue audit regulatory requirement paid time leaf absence revised internal ehss standard employee stock purchase program also invest employee physical emotional social financial wellbeing global wellness program healthier together employee obtain information benefit inperson employee access program fy17 approximately presentation ondemand webbased tool askhr support 43 percent 38700 employee participated virtual benefit counselor alex safety record recognition value people diligence innovation believe effort fy15 fy16 fy17 recognized manager employee celebrate employee injury incident rate 050 045 039 colleague success global recognize program employee lostrestricted 023 022 021 honor model leadership expectation help u drive workday case rate progress toward patientcentered mission fy17 recognized 77800 employee including 3370 outstanding ethical behavior fatality 1 0 0 number workrelated injury illness serious enough require treatment beyond first aid per 100 employee working full year safety wellness number workrelated injury illness serious enough cause employee miss one workday one workday restricted duty per 100 employee working full year fy15 fy16 data include legacy medtronic legacy covidien employee injury rate include ensuring safety employee top priority u portion asia eastern eu latin america sale continued make progress 2020 health safety improvement goal include healthier together identifying injury trend reducing injury risk fy15 fy16 fy17 reducing ergonomicrelated injury rate employee registered wellness platform 50769 38725 accelerating global employee training environmental workforce participation rate 57 43 health safety requirement historic participation rate based questionnaire longer used employee participation measured registration wellness platform historic data removed medtronics new wellness website launched fy17 q4 employee must reregister platform caused decrease overall reported participation rate employee 41 data summary medtronic global workforce global fulltime fy15 fy16 fy17 fy15 fy16 fy17 total 46368 90549 94834 total 45084 88520 92943 female 22657 44371 46769 30 7967 18043 20013 asia pacific 4950 12363 13188 3150 28341 52891 55243 female 2169 5381 5745 51 8776 16546 17687 canada 792 1544 1634 female 21530 42687 45181 female 495 900 956 asia pacific 2113 5299 5665 europecentral asiamiddle eastafrica 9754 17820 18854 canada 484 896 947 female 5069 9149 9562 e uropecentral asiamiddle eastafrica 4192 7939 8386 latin america 3786 16425 17621 latin america 2628 10013 10971 u puerto rico 12113 18540 19212 female 2628 10019 10983 employee population data expressed may vary 2017 10k form depending time year u puerto rico 27086 42397 43537 data gathered fy15 include legacy covidien employee female 12296 18922 19523 1041 record outofbound value included age break 595 record specify gender 478 record outofbound value included age break 123 record specify gender employee population data expressed may vary 2017 10k form depending time year number region based female employee data gathered fy15 include legacy covidien employee 595 record specify gender 123 record specify gender employment type global parttime fy17 fy15 fy16 fy17 support staff 42531 total 1284 2029 1891 female 25142 30 66 228 172 professional 41368 3150 985 1373 1291 female 17750 51 233 427 428 management 9816 female 1127 1684 1588 asia pacific 56 82 80 female 3429 canada 11 4 9 vps higher 528 uropecentral asiamiddle eastafrica e 877 1210 1176 female 141 latin america 0 6 12 u puerto rico 183 382 311 employee population data expressed may vary 2017 10k form depending time year data gathered employee population data expressed may vary 2017 10k form depending time year 591 employee job category designation data gathered management manager senior manager director senior director fy15 include legacy covidien employee 1041 record outofbound value included age break 595 record specify gender 478 record outofbound value included age break 123 record specify gender number region based female employee employee 42 new employee hire employee turnover voluntary involuntary fy15 fy16 fy17 fy15 fy16 fy17 total 5407 16026 17408 total 4453 13509 15022 30 2384 7344 9591 30 1174 5313 6649 3150 2702 6673 6801 3150 2492 6216 6295 51 321 867 1016 51 787 1980 2078 female 2574 7266 8234 female 2236 6873 7167 asia pacific 431 1189 1184 asia pacific 292 816 826 canada 29 132 126 canada 18 181 128 europecentral asiamiddle eastafrica 440 1255 1350 europecentral asiamiddle eastafrica 517 1073 1312 latin america 255 2027 2894 latin america 383 2455 2462 u puerto rico 1419 2663 2680 u puerto rico 1026 2348 2439 employee population data expressed may vary 2017 10k form depending time year fy15 include legacy covidien employee data gathered 105 record value bound example age0 81 record specify gender fy15 include legacy covidien employee 1440 record value bound example age0 674 record specify gender 1142 record value bound example age0 672 record specify gender number region based female employee 1510 record value bound example age0 578 record specify gender fiscal year 2015 include employee hired terminated within year number region based female employee employee 43 report reporting reflects way business integrating social assurance forwardlooking statement environmental ethical financial performance fourth sought independent verification report annual integrated performance report comprising financial practice place internally validate data nonfinancial information forwardlooking statement subject risk uncertainty report cover issue material business described medtronics periodic report file stakeholder summarized sustainability risk security exchange commission sec actual result may differ opportunity section materially anticipated result report prepared accordance g4 core guideline global reporting initiative gri internationally recognized framework information sustainability reporting content also informed reporting requirement sustainability accounting standard board sasb additional business sustainability information please refer medical equipment supply dow jones sustainability index sec filing including form 10k proxy filing well press release cdp disclosure scope data value stakeholder view provide feedback request information please email integratedreportmedtroniccom unless otherwise stated performance data cover fiscal year 2017 fy17 april 29 2016 april 28 2017 previous report fy16 published november 2016 report includes data medtronic plc consolidated subsidiary environmental health safety data cover manufacturing research development facility reported data best estimate entity omitted metric impact overall data less 10 percent exclusion noted throughout report financial information reported u dollar report 44 integration index integrated reporting medtronic report provides overview sustainability integrated medtronics business index highlight important way social environmental ethical performance tied business success section integration touchpoint subsection sustainability sustainability risk management sustainability management risk opportunity business continuity risk management reducing sustainability risk meeting customer expectation sustainability performance creating opportunity responding investor requirement creating opportunity economic contribution driving revenue growth emerging market financial performance society supporting local community operational cost expenditure aligning business healthcare need strategic acquisition investment acquisition investment philanthropy percentage pretax profit philanthropy product donation philanthropy access investing rd spur new product service therapy innovation therapy innovation pursuing valuebased healthcare managed service improved clinical outcome economic value value alignment addressing affordability pricing model economic value building capacity local infrastructure healthcare provider patient increase expanding global access effective use product service addressing healthcare need worldwide innovative business model expanding global access integration index 45 section integration touchpoint subsection product quality expanding commitment product quality supplier engagement responsibility quality enhancing postmarket surveillance improve patient outcome product use performance monitoring facility avoid disruption operation supply chain maintaining quality facility maintaining high ethical standard animal research support brand reputation preclinical research license operate product stewardship reducing waste saving cost approach responsible supplier quality management avoid error impact patient health supplier quality management supply management damage reputation global human right labor standard supplier diversity program support responsible supply management brand reputation license operate ethic sale reducing risk distribution channel ethical business conduct marketing protecting patient privacy health data customer data security governance ethical conduct integral part credibility success ethical workplace engagement advocating public policy advance mission business objective public policy operation environmental health safety sustainability ehss management improve management approach operational efficiency save cost employee investing employee personal professional development drive business success investing workforce building inclusion diversity enabler innovation inclusion diversity integration index 46 nongaap financial measure report contains financial measure including free cash flow figure defined operating cash flow less property plant equipment addition revenue growth rate diluted eps figure constant currency basis adjusted extra week fiscal year 2016 constant currency growth measure change revenue current prior year period using average exchange rate effect applicable prior year period figure nongaap financial measure applicable sec rule regulation management belief referring constant currency growth rate useful way evaluate underlying performance medtronics sale medtronic generally us nongaap financial measure facilitate management review operational performance company basis strategic planning nongaap financial measure considered supplemental substitute financial information prepared accordance generally accepted accounting principle gaap company definition nongaap measure may similar measure presented company nongaap financial measure exclude effect item increase decrease company reported result operation therefore management strongly encourages investor review company consolidated financial statement publicly filed report entirety nongaap financial measure 47 medtronic plc fy17 net income diluted eps gaap nongaap reconciliation unaudited million except per share data fiscal year ended april 28 2017 income provision net income attributable diluted effective income tax medtronic eps tax rate gaap 4602 4028 289 126 nongaap adjustment impact inventory stepup 38 24 002 368 special charge 100 63 005 370 restructuring charge net 373 272 020 271 certain litigation charge 300 190 014 367 acquisitionrelated item 230 156 011 322 amortization intangible asset 1980 1460 105 263 certain tax adjustment net 202 015 nongaap 7623 6395 460 162 foreign currency impact 017 constant currency adjusted 477 see description nongaap financial measure contained page 47 report data schedule intentionally rounded nearest 001 therefore may sum nongaap adjustment relate charge benefit management belief may may recur similar materiality impact result future period represents amortization stepup fair value inventory acquired connection heartware acquisition charge represents contribution medtronic foundation integrationrelated cost incurred connection covidien acquisition charge incurred connection pending divestiture portion patient monitoring recovery division cardinal health net charge primarily relates tax effect recognition outside basis difference certain subsidiary included expected divestiture portion patient monitoring recovery division cardinal health certain tax charge recorded connection redemption intercompany minority interest resolution various tax matter prior period nongaap financial measure 48 medtronic plc fy17 net income diluted eps gaap nongaap reconciliation unaudited million except per share data fiscal year ended april 29 2016 income operation net income attributable diluted effective tax medtronic eps tax rate gaap 4336 3538 248 184 nongaap adjustment impact inventory stepup 226 165 012 270 special charge 70 44 003 371 restructuring charge net 299 221 015 261 certain litigation charge 26 17 001 346 acquisitionrelated item 283 212 015 251 amortization intangible asset 1931 1467 103 240 loss previously held forward starting interest 45 29 002 356 swap rate debt tender premium 183 118 008 355 certain tax adjustment net 417 029 nongaap 7399 6228 437 158 yearoveryear percent change gaap 17 nongaap 5 constant currency adjusted nongaap 9 see description nongaap financial measure contained page 47 report data schedule intentionally rounded nearest 001 therefore may sum nongaap adjustment relate charge benefit management belief may may recur similar materiality impact result future period represents amortization stepup fair value inventory acquired connection covidien acquisition impairment debt investment primarily related u income tax expense resulting company completion internal reorganization ownership certain legacy covidien business reduced cash investment held medtronics uscontrolled nonus subsidiary also includes benefit related establishment deferred tax asset tax basis excess book basis wholly owned u subsidiary company disposed due 5253 week fiscal year calendar company additional selling week first quarter fiscal year 2016 difficult calculate exact impact extra week company estimate 008 010 benefit nongaap diluted earnings per share eps first quarter fiscal year 2016 company estimate adjusting extra week nongaap earnings diluted eps operating margin increase approximately 8 9 percent approximately 11 12 percent approximately 1 percent respectively constant currency constant week basis compared prior fiscal year nongaap financial measure 49 medtronic plc reconciliation operating cash flow free cash flow unaudited million fy15 fy16 fy17 net cash provided operating activity 4902 5218 6880 addition property plant equipment 571 1046 1254 free cash flow 4331 4172 5626 investor consider nongaap measure addition substitute financial performance measure prepared accordance u gaap free cash flow represents operating cash flow less property plant equipment addition fy17 reconciliation worldwide geographic reported growth worldwide geographic constant currency growth unaudited million fiscal year reported fiscal year constant currency adjusted fy16 fy17 reported currency fy17 constant total total growth impact total currency revenue growth u 16422 16663 1 16663 1 nonus developed 8708 9085 4 44 9041 4 emerging market 3703 3962 7 78 4040 9 total 28833 29710 3 34 29744 3 u includes united state u territory nonus developed market include japan australia new zealand korea canada country western europe emerging market include country middle east africa latin america eastern europe country asia included nonus developed market previously defined constant currency growth nongaap financial measure measure change revenue current prior year period using average exchange rate effect applicable prior year period fiscal year 2016 53week year extra week included first quarter result difficult calculate impact extra week company estimate extra week impact worldwide fiscal year 2016 first quarter revenue approximately 450 million excluding approximately 450 million fy16 total revenue would result approximately 5 percent overall growth low double digit emerging market growth case constant currency constant week basis nongaap financial measure 50 medtronic plc reconciliation diluted eps nongaap eps dividend payout ratio unaudited fy15 fy16 fy17 diluted eps 241 248 289 nongaap adjustment impact inventory stepup 041 012 002 restructuring charge net 016 015 020 acquisitionrelated item 039 015 011 amortization intangible asset 049 103 105 certain litigation charge 002 001 014 certain tax adjustment net 031 029 015 special charge gain net 002 003 005 loss previously held forward starting interest rate swap 002 debt tender premium 008 impact product technology upgrade commitment 006 impact acquisition interest expense 004 nongaap eps 428 437 460 currency impact 047 017 adjusted nongaap eps 484 477 dividend per share 122 152 172 dividend payout ratio 40 63 69 impact nongaap adjustment 10 27 30 dividend payout ratio nongaap basis 30 36 39 investor consider nongaap measure addition substitute financial performance measure prepared accordance u gaap data schedule intentionally rounded nearest 001 therefore may sum nongaap adjustment relate charge gain management belief may may recur similar materiality impact result future period represents amortization stepup fair value inventory acquired connection heartware acquisition represents amortization stepup fair value inventory acquired connection covidien acquisition integrationrelated cost incurred connection covidien acquisition charge incurred connection pending divestiture portion patient monitoring recovery division cardinal health net charge primarily relates tax effect recognition outside basis difference certain subsidiary included expected divestiture portion patient monitoring recovery division cardinal health certain tax charge recorded connection redemption intercompany minority interest resolution various tax matter prior period primarily relates u income tax expense resulting company completion internal reorganization ownership certain legacy covidien business reduced cash investment held medtronics uscontrolled nonus subsidiary also includes benefit related establishment deferred tax asset tax basis excess book basis wholly owned u subsidiary company disposed primarily relates 329 million tax expense anticipated resolution kyphon acquisitionrelated issue irs charge represents contribution medtronic foundation impairment debt investment special gain includes 64 million aftertax charitable contribution made medtronic foundation 25 million aftertax gain divestiture recognized connection sale microfrance product line 62 million aftertax net gain recognized connection sale certain equity method investment relates loss incurred unwinding forward starting interest rate swap previously entered advance planned debt issuance longer expected post internal reorganization probable reasonably estimable charge related crhf global comprehensive program home based monitor due industry conversion analog digital technology represents incremental interest expense incurred hold 17 billion debt december 10 2014 end third quarter fy15 december 10 2014 medtronic inc issued 17 billion debt finance part cash component covidien acquisition consideration including payment certain transaction financing expense working capital general corporate purpose nongaap financial measure 51 medtronic plc reconciliation net income nongaap net income unaudited million fy15 fy16 fy17 gaap net income attributable medtronic 2675 3538 4028 nongaap adjustment impact inventory stepup 455 165 24 restructuring charge net 180 221 272 acquisitionrelated item 433 212 156 amortization intangible asset 538 1467 1460 certain litigation charge 27 17 190 certain tax adjustment net 349 417 202 special charge gain net 23 44 63 loss previously held forward starting interest rate swap 29 debt tender premium 118 impact product technology upgrade commitment 61 impact acquisition interest expense 49 nongaap net income attributable medtronic 4744 6228 6395 dividend 1337 2139 2376 share repurchase net 1271 2339 3116 total payout ratio 97 127 136 impact nongaap adjustment 42 55 50 total payout ratio nongaap basis 55 72 86 investor consider nongaap measure addition substitute financial performance measure prepared accordance u gaap data schedule intentionally rounded nearest 001 therefore may sum nongaap adjustment relate charge benefit management belief may may recur similar materiality impact result future period represents amortization stepup fair value inventory acquired connection heartware acquisition represents amortization stepup fair value inventory acquired connection covidien acquisition integrationrelated cost incurred connection covidien acquisition charge incurred connection pending divestiture portion patient monitoring recovery division cardinal health net charge primarily relates tax effect recognition outside basis difference certain subsidiary included expected divestiture portion patient monitoring recovery division cardinal health certain tax charge recorded connection redemption intercompany minority interest resolution various tax matter prior period primarily relates u income tax expense resulting company completion internal reorganization ownership certain legacy covidien business reduced cash investment held medtronics uscontrolled nonus subsidiary also includes benefit related establishment deferred tax asset tax basis excess book basis wholly owned u subsidiary company disposed primarily relates 329 million tax expense anticipated resolution kyphon acquisitionrelated issue irs charge represents contribution medtronic foundation impairment debt investment special gain includes 64 million aftertax charitable contribution made medtronic foundation 25 million aftertax gain divestiture recognized connection sale microfrance product line 62 million aftertax net gain recognized connection sale certain equity method investment relates loss incurred unwinding forward starting interest rate swap previously entered advance planned debt issuance longer expected post internal reorganization probable reasonably estimable charge related crhf global comprehensive program home based monitor due industry conversion analog digital technology represents incremental interest expense incurred hold 17 billion debt december 10 2014 end third quarter fy15 december 10 2014 medtronic inc issued 17 billion debt finance part cash component covidien acquisition consideration including payment certain transaction financing expense working capital general corporate purpose nongaap financial measure 52